For research use only. Not for therapeutic Use.
S19-1035（Cat No.:I042357）is a small molecule compound under investigation for its potential in cancer therapy. It functions as an inhibitor of specific kinases involved in cell survival and proliferation, particularly those implicated in tumor growth and metastasis. By targeting these kinases, S19-1035 aims to disrupt critical signaling pathways that promote cancer cell survival, offering a strategy to inhibit tumor progression. Research is ongoing to evaluate its effectiveness in various cancers, including those resistant to conventional treatments. S19-1035 may present a promising option for targeted cancer therapies, potentially improving treatment outcomes.
| CAS Number | 2986319-18-8 |
| Synonyms | N-(2-chlorophenyl)-2-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]benzamide |
| Molecular Formula | C19H17ClN2O3 |
| Purity | ≥95% |
| IUPAC Name | N-(2-chlorophenyl)-2-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]benzamide |
| InChI | InChI=1S/C19H17ClN2O3/c1-12-15(13(2)25-22-12)11-24-18-10-6-3-7-14(18)19(23)21-17-9-5-4-8-16(17)20/h3-10H,11H2,1-2H3,(H,21,23) |
| InChIKey | DPKPKQOCNMAUHN-UHFFFAOYSA-N |
| SMILES | CC1=C(C(=NO1)C)COC2=CC=CC=C2C(=O)NC3=CC=CC=C3Cl |
